Summary
Endothelin alters central sympathetic responses, but the resultant effects on arrhythmogenesis are unknown. We examined ventricular tachyarrhythmias after endothelin receptor-A blockade in the brain of Wistar rats with acute myocardial infarction. For this aim, BQ-123 (n=6) or phosphate-buffered saline (n=6) were injected intracerebroventricully. After 10min, the left coronary artery was ligated, followed by implantation of telemetry transmitters. Electrocardiography and voluntary activity (as a surrogate of acute left ventricular failure) were continuously monitored for 24h.
Infarct-size was similar in the two groups. There were fewer episodes of ventricular tachyarrhythmias of shorter average duration in treated rats, leading to markedly shorter total duration (12.3±8.9s), when compared to controls (546.2 ±130.3s). Voluntary activity increased in treated rats during the last hours of recording, but bradyarrhythmic episodes were comparable between the two groups.
Endothelin receptor-A blockade in the brain of rats decreases the incidence of ventricular tachyarrhythmias post-ligation, without affecting bradyarrhythmic episodes. These findings call for further research on the pathophysiologic role of endothelin during acute myocardial infarction.
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Myocardial infarction; brain; endothelin; A-receptor; ventricular tachyarrhythmias -1 -Acute myocardial infarction (MI) is often complicated by ventricular tachyarrhythmias (VTs) that occur during the early stage of ischemia, or subsequently, during evolving MI (Kolettis, 2013) . The latter VTs, referred to as phase-II arrhythmogenesis, have an ominous prognosis not only in the out-of-hospital setting, but also in hospitalized patients (Piccini et al. 2008) .
Central sympathetic activation, occurring frequently during acute MI, contributes to the genesis of phase-II VTs (Kolettis, 2018) . Despite continuing research on this topic, the underlying pathophysiology remains incompletely understood. Endothelin-1 (ET-1) has attracted considerable interest in this regard, with its actions as a mediator of central sympathetic responses reported shortly after its discovery (Ouchi et al. 1989 ).
For instance, intracerebroventricular (i.c.v.) injections of ET-1 in rats were shown to alter heart rate (HR) and plasma catecholamines (Kuwaki et al. 1997) . These actions are likely exerted via ETA-receptors, which are abundantly located in central neurons (Mosqueda-Garcia et al. 1993 ). The present study, performed in the rat-model of acute MI, explored the hypothesis that ETA-receptor blockade in the brain decreases the incidence of phase-II VTs.
The experiments were conducted on 12 Wistar-rats (258±7g), housed under optimal conditions. The study was approved by the institutional ethics' committee and adheres to the European guidelines on laboratory animal care. The rats were mechanically ventilated at 85breaths/min and anesthetized with 2.5%-sevoflurane, a regimen not affecting autonomic responses (Kurosawa et al. 1989) . They were placed on a stereotaxic frame (David Kopf, CA, USA), and 10μl of phosphate-buffered saline (PBS) was slowly (10min) injected i.c.v. via a Hamilton-needle, according to previous guides (DeVos and Miller, 2013) . The following coordinates were used relative to the bregma:
1.08mm anteroposteriorly, ±1.9mm mediolaterally and -3.7mm dorsoventrally. Based on previous data (Mosqueda-Garcia et al. 1993) , the injections contained 10nmol of (the selective ETA-receptor antagonist) BQ-123 (directly dissolved in PBS) in the treatment group, with only PBS in controls; 10min thereafter, the left coronary artery was permanently ligated midway between its origin and the apex, with the induced MI validated by ST-segment elevation in a 6-lead ECG. After 30min, telemetrytransmitters (TCA-F40, DSI, MN, USA) were implanted quickly (<10min) in survivors.
The opioid-analgesic buprenorfine (0.05mg/kg) was injected intraperitoneally prior to -2 -extubation in both groups, thus eliminating pain as a confounding factor. The protocol, depicted in Fig.1, ( i.c.v. administration, anesthesia, analgesia) ensures the comparability between the two groups. The rats regained consciousness within 3min after discontinuation of anesthesia, and were then placed on a receiver (RCA-1020, DSI), capturing the signal continuously for 24h; this setting enables the assessment in the conscious, unrestrained state.
Premature ventricular contractions, couplets and triplets were counted in the treatment and control groups, each of n=6 animals. The number and duration of VTepisodes, as well as bradyarrhythmic events were also recorded. Lastly, voluntary motor-activity was assessed by the number of counts, generated by strengthvariations in telemetry-signal, relative to animal location; these counts correlate 
2010).
Values are reported as mean±standard error of the mean; after examination for normality with the Kolmogolov-Smirnov test, the variables displaying skewed distribution were transformed according to Box-Cox analysis. Subsequently, differences between the two groups were assessed with the Student's t-test, whereas changes over time were assessed with analysis of variance for repeated measures, followed by post-hoc Duncan's test. Statistical significance was set at p<0.05.
Infarct-size (as % of LV area) was similar between treated rats (28.7±1.9) and controls (27.3±1.6). HR remained stable in controls throughout the 24h-period, but it increased during the delayed stage in the treatment group (Fig.2A) . The total number of bradyarrhythmic episodes was comparable, namely 52±23 in treated rats and 32±11 in controls; likewise, the total duration of these episodes did not differ, being 28.8±12.3s and 17.1±5.6s, respectively. The total number of premature ventricular contractions was also similar, at 125±63 in the treatment group and 207±52 in controls, but fewer couplets were observed in the treatment group (6±3) than in controls (13±2).
There were fewer VT-episodes in treated rats (8±5) than in controls (68±25 ,   Fig.2B) ; moreover, the average duration of each episode was shorter in treated animals (0.7±0.4s) than in controls (11.3±3.6s). As a result, the total duration of VTs was markedly shorter in the treatment group (12.3±8.9s) than in controls (546.2±130.3s, Fig.2C ). Compared to the early phase, voluntary activity increased in both groups during the delayed time-period, but such increase was more pronounced in treated rats (Fig.2D) .
Acute MI is often complicated by VTs, with highest incidence during the initial 24h.
Here, we investigated the antiarrhythmic potential of ETA-receptor blockade in the brain of rats; this model is considered particularly useful, as the rat displays multiple VT-episodes in response to coronary ligation (Opitz et al. 1995 In summary, our study shows that ETA-receptor blockade in the brain decreases delayed VTs during acute MI in rats, without concurrent bradyarrhythmia. These preliminary findings justify further research on the effects of ET-1 on autonomic responses during acute MI.
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